Aegis Therapeutics LLC is a biotechnology company based in San Diego, United States, founded in 2003. The company specializes in drug delivery technology, with a focus on commercializing patented drug delivery and formulation technologies through product-specific licenses. Aegis' Intravail® drug delivery technology enables the non-invasive delivery of a wide range of drugs, including proteins, peptides, and non-peptides, through oral, buccal, and intranasal administration routes with high bioavailability. Additionally, their ProTek® excipients stabilize and reduce unwanted immunogenicity of protein and peptide therapeutics without the oxidative damage caused by polysorbate surfactants found in most protein injectable drugs. Aegis Therapeutics LLC continues to innovate in the biotechnology space, offering solutions for non-invasive drug delivery and formulation.
There is no investment information
No recent news or press coverage available for Aegis Therapeutics LLC.
We care about your data, and we'd love to use cookies make your experience better.
